UnitedHealth Group Incorporated (NYSE:UNH) Stock Has Consensus Target Price of $462.59

Shares of UnitedHealth Group Incorporated (NYSE:UNH) have received an average recommendation of “Moderate Buy” from the twenty-eight research firms that are currently covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $463.57.

UNH has been the topic of several research reports. Barclays decreased their target price on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 14th. BMO Capital Markets set a $512.00 price target on UnitedHealth Group in a report on Tuesday, July 21st. The Goldman Sachs Group boosted their price target on UnitedHealth Group from $435.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. New Street Research set a $402.00 price objective on UnitedHealth Group in a research report on Friday, October 9th. Finally, TD Cowen reissued a “hold” rating and set a $402.00 target price on shares of UnitedHealth Group in a report on Thursday, October 15th.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat and raised outlook: UnitedHealth reported adjusted earnings of $4.69 per share versus the $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Management raised its 2026 adjusted EPS outlook to at least $20.50, reinforcing investor confidence in operating execution and helping drive renewed interest in the shares. UnitedHealth Group Has The Market Asking A Bigger Question
• Positive Sentiment: Improving investor sentiment: Recent gains have followed the earnings beat and guidance increase, with analysts and investors reassessing medical-cost trends and the company’s ability to achieve its longer-term growth targets. Some coverage also points to potential efficiency gains from artificial intelligence and UnitedHealth’s diversified business model. Is UnitedHealth Group Stock a Buy After Another Solid Quarter?
• Neutral Sentiment: Healthcare-sector interest: UnitedHealth’s results are supporting interest in healthcare ETFs that include UNH, although diversified funds may reduce exposure to company-specific and Medicaid-related risks. A potentially divided government after the midterm elections could also be broadly favorable for healthcare stocks, but the policy outcome remains uncertain. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings
• Negative Sentiment: Valuation concerns: One analyst downgraded UnitedHealth from “strong buy” to “buy,” arguing that the stock appears fairly valued near 20 times forward earnings. The view suggests the recent rally may already reflect much of the earnings recovery, making additional gains more dependent on sustained execution. UnitedHealth Rating Downgrade
• Negative Sentiment: Coverage and enrollment pressure: A sharp decline in individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans in 2027 highlight regulatory, membership and pricing risks for health insurers. These developments could pressure growth and increase uncertainty around future medical costs and retention. Health Insurance Market Enrollment Decline

UnitedHealth Group Stock Performance

NYSE UNH opened at $406.99 on Tuesday. The stock has a market cap of $365.31 billion, a PE ratio of 23.24, a P/E/G ratio of 1.45 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The firm has a 50-day moving average of $387.04 and a 200-day moving average of $386.47. UnitedHealth Group has a 52-week low of $255.96 and a 52-week high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The business had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts anticipate that UnitedHealth Group will post 20.64 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.19% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Wellington Altus USA Inc. grew its holdings in shares of UnitedHealth Group by 97.1% during the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 33 shares in the last quarter. Security National Bank of SO Dak bought a new stake in UnitedHealth Group during the second quarter worth about $29,000. Nvwm LLC grew its stake in UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 33 shares in the last quarter. Aberdeen Wealth Management LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $31,000. Finally, Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.